CORC

在结果中检索

CORC

浏览/检索结果: 共75条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy 期刊论文
2019, 卷号: 18
作者:  Chen, Li;  Hao, Ying;  Cong, Xiliang;  Zou, Menghua;  Li, Sen
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study 期刊论文
2019, 卷号: 37, 期号: 29, 页码: 2610-2619
作者:  Ma Fei;  Ouyang Quchang;  Li Wei;  Jiang Zefei;  Tong Zhongsheng
收藏  |  浏览/下载：32/0  |  提交时间：2020/01/03
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial 期刊论文
2019, 卷号: 25, 期号: 17, 页码: 5212-5220
作者:  Li Qiao;  Guan Xiuwen;  Chen Shanshan;  Yi Zongbi;  Lan Bo
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03
Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study 期刊论文
2018, 卷号: 6, 期号: 10, 页码: 373-383
作者:  Ren, Deng-Feng;  Zheng, Fang-Chao;  Zhao, Jun-Hui;  Shen, Guo-Shuang;  Ahmad, Raees
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 会议论文
CANCER RESEARCH, 2018-02-01
作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei
收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03
Conversion chemotherapy with capecitabine and oxaliplatin for colorectal cancer with potentially resectable liver metastases: A phase II, open-label, single-arm study 期刊论文
2018, 卷号: 14, 期号: 4, 页码: 772-779
作者:  Li, Yong;  Li, Guo-Xin;  Chu, Zhong-Hua;  Hao, Chun-Yi;  Jiang, Zhi-Wei
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 期刊论文
2018, 卷号: 78, 期号: 4
作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
Long-term results of postoperative chemoradiation therapy with capecitabine and oxaliplatin versus capecitabine alone for locally advanced rectal cancer: A randomized, multicenter, phase III trial 会议论文
ANNALS OF ONCOLOGY, 2018-10-01
作者:  Li, N.;  Jin, J.;  Li, Y.;  Zhu, Y.;  Wang, W.
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Long-term results of postoperative chemoradiation therapy with capecitabine and oxaliplatin versus capecitabine alone for locally advanced rectal cancer: A randomized, multicenter, phase III trial 期刊论文
2018, 卷号: 29, 页码: 153-153
作者:  Li, N.;  Jin, J.;  Li, Y.;  Zhu, Y.;  Wang, W.
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/03
Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial 期刊论文
2017, 卷号: 18, 期号: 3, 页码: 371-383
作者:  Zhang, Pin;  Sun, Tao;  Zhang, Qingyuan;  Yuan, Zhongyu;  Jiang, Zefei
收藏  |  浏览/下载：12/0  |  提交时间：2020/01/04

©版权所有 ©2017 CSpace - Powered by CSpace